We are live on ! Find out more
ROIV icon

Roivant Sciences
ROIV

337 hedge funds and large institutions have $5.8B invested in Roivant Sciences in 2025 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 115 increasing their positions, 110 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

690% more call options, than puts

Call options by funds: $87.5M | Put options by funds: $11.1M

74% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 35

8% more funds holding

Funds holding: 312 → 337 (+25)

5% more repeat investments, than reductions

Existing positions increased: 115 | Existing positions reduced: 110

3% more capital invested

Capital invested by funds: $5.63B → $5.8B (+$172M)

2.47% less ownership

Funds ownership: 78.15% → 75.68% (-2.5%)

28% less funds holding in top 10

Funds holding in top 10: 18 → 13 (-5)

Holders
337
Holders Change
+25
Holders Change %
+8.01%
% of All Funds
4.44%
Holding in Top 10
13
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-27.78%
% of All Funds
0.17%
New
61
Increased
115
Reduced
110
Closed
35
Calls
$87.5M
Puts
$11.1M
Net Calls
+$76.4M
Net Calls Change
+$49.1M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$95M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$57.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$41.7M
4
PA
Perceptive Advisors
New York
+$36.1M
5
O
OrbiMed
New York
+$30.1M

Top Sellers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
-$395M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$128M
3
Invesco
Invesco
Georgia
-$88.8M
4
TCIM
TOMS Capital Investment Management
New York
-$44.4M
5
Norges Bank
Norges Bank
Norway
-$43M
Name Holding Trade Value Shares
Change 		Change in
Stake
UOC
351
UBS O'Connor
Illinois
– -$432K -42,819 Closed
BOCH
352
Blue Owl Capital Holdings
New York
– -$394K -39,003 Closed
WC
353
Wexford Capital
Florida
– -$373K -37,000 Closed
Mariner
354
Mariner
Kansas
– -$359K -35,621 Closed
CM
355
Capula Management
Cayman Islands
– -$278K -27,574 Closed
USAA
356
United Services Automobile Association
Texas
– -$285K -27,494 Closed
1C
357
111 Capital
France
– -$268K -26,536 Closed
CFM
358
Catalyst Funds Management
Australia
– -$237K -23,440 Closed
Stifel Financial
359
Stifel Financial
Missouri
– -$221K -21,863 Closed
GWM
360
Greenwich Wealth Management
Connecticut
– -$161K -15,945 Closed
DC
361
Diametric Capital
Massachusetts
– -$130K -12,921 Closed
QL
362
Quarry LP
New York
– -$129K -12,800 Closed
QC
363
Quantessence Capital
New York
– -$126K -12,513 Closed
GCP
364
GSA Capital Partners
United Kingdom
– -$117K -11,644 Closed
C
365
Certuity
Florida
– -$101K -10,000 Closed
CCM
366
Coldstream Capital Management
Washington
– -$40.3K -3,994 Closed
SW
367
SVB Wealth
Massachusetts
– -$2.2K -218 Closed
SAM
368
Smartleaf Asset Management
Massachusetts
– -$1.93K -186 Closed
QC
369
Quent Capital
New York
– -$1.03K -102 Closed
SC
370
Swan Capital
Florida
– -$757 -75 Closed
ACA
371
American Capital Advisory
Idaho
– -$192 -19 Closed
TFM
372
TFC Financial Management
Massachusetts
– -$21 -2 Closed
11 12 13 14
15

ROIV Hedge Fund Activity: Q2 2025 in Review

337 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q2 2025, worth a combined $5.8B — up 3.1% from $5.63B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new ROIV positions and 35 closed out — a net gain of 26 holders — while 115 added to existing stakes and 110 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $95M. The largest seller was QVT Financial, cutting an estimated $395M.

  • 337 institutional investors held Roivant Sciences (ROIV) as of Q2 2025, up from 312 in Q1 2025.
  • Funds reported $5.8B of Roivant Sciences stock for Q2 2025, up 3.1% quarter-over-quarter.
  • 61 funds opened new Roivant Sciences positions in Q2 2025 and 35 closed out, a net change of +26 holders.
  • The largest Roivant Sciences buyer in Q2 2025 was Morgan Stanley, an estimated $95M added.
  • The largest Roivant Sciences seller in Q2 2025 was QVT Financial, an estimated $395M sold.

Based on aggregated 13F filings for Q2 2025.